Matthew J Voss

age ~55

from New Providence, NJ

Get Report

Also known as:

Matthew Jeffer Voss
Matt J Voss

Phone and address:: 90 Inwood Rd, Murray Hill, NJ 07974
(908)5162069

Connected to:

Matthew Voss Phones & Addresses

90 Inwood Rd, New Providence, NJ 07974 • (908)5162069
Bremen, ME
Berkeley Heights, NJ
Brooklyn, NY
Millburn, NJ
Andover, MA
Waltham, MA
Portland, ME
Union, NJ
Providence, RI
New Providnce, NJ
298 Warren St, Brooklyn, NY 11201

Work

Position:

Apps in the app store / contributor

Education

School / High School:

Pensacola Christian College
2001
Specialities:

Computer Science

Lawyers & Attorneys

Matthew Voss - Lawyer

view source

ISLN:

916797636

Admitted:

2001

University:

University of Nevada, Las Vegas, B.A., 1998

Law School:

University of California at Berkeley, J.D., 2001

Matthew Voss - Lawyer

view source

Specialties:

Health Care
Copyright Infringement
Copyright Infringement
Civil Litigation
Insurance Defense
Construction Defects

ISLN:

913986699

Admitted:

1998

University:

Illinois State University, B.S., 1993

Law School:

Southwestern University School of Law, J.D., 1997

License Records

Matthew Voss

License #:

27392 - Expired

Category:

Nursing Support

Issued Date:

Aug 11, 1994

Effective Date:

May 28, 1998

Type:

Nurse Aide

Medicine Doctors

Matthew R. Voss

view source

Specialties:

Cardiovascular Disease

Work:

Maryland Cardiovascular Specialist
3407 Wilkens Ave STE 300, Baltimore, MD 21229
(410)6445111 (phone), (410)6442715 (fax)

Education:

Medical School
Southern Illinois University School of Medicine
Graduated: 1998

Procedures:

Angioplasty
Cardiac Stress Test
Pacemaker and Defibrillator Procedures
Cardiac Catheterization
Cardioversion
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)

Conditions:

Mitral Valvular Disease
Abdominal Hernia
Acute Myocardial Infarction (AMI)
Anemia
Anxiety Phobic Disorders

Languages:

English
Spanish

Description:

Dr. Voss graduated from the Southern Illinois University School of Medicine in 1998. He works in Baltimore, MD and specializes in Cardiovascular Disease. Dr. Voss is affiliated with Medstar Union Memorial Hospital, Saint Agnes Hospital, University Of Maryland Saint Joseph Medical Center and University Of Maryland Upper Chesapeake Medical Center.

Matthew R. Voss

view source

Specialties:

Family Medicine

Work:

Manchester Community Health Center
145 Hollis St FL 2, Manchester, NH 03101
(603)6269500 (phone), (603)6269523 (fax)

Languages:

Arabic
English
Spanish

Description:

Mr. Voss works in Manchester, NH and specializes in Family Medicine. Mr. Voss is affiliated with Elliot Hospital.

Us Patents

Lactams As Modulators Of Chemokine Receptor Activity
view source
US Patent:

7338975, Mar 4, 2008
Filed:

Feb 11, 2004
Appl. No.:

10/776586
Inventors:

Percy H. Carter - Princeton NJ, US
Matthew E. Voss - Nassau NY, US
Assignee:

Bristol-Myers Squibb Co. - Princeton NJ
International Classification:

A61K 31/4015
C07D 207/12
C07D 207/26
US Classification:

514424, 548543, 548550
Abstract:

The present application describes modulators of MCP-1 of formula (I):.

Substituted Piperidines That Increase P53 Activity And The Uses Thereof
view source
US Patent:

20120208844, Aug 16, 2012
Filed:

Oct 5, 2010
Appl. No.:

13/501685
Inventors:

Stephane L. Bogen - Somerset NJ, US
Yao Ma - Lexington MA, US
Yaolin Wang - Short Hills NJ, US
Brian Robert Lahue - Millbury MA, US
Latha G. Nair - Edison NJ, US
Manami Shizuka - Lexington MA, US
Matthew Ernst Voss - Nassau NY, US
Weidong Pan - Somerset NJ, US
Yuan Tian - Newton MA, US
Bheemashankar A. Kulkarni - Bangalore, IN
Craig R. Gibeau - Natick MA, US
Yuan Liu - Belmont MA, US
Giovanna Scapin - Staten Island NY, US
Diane Rindgen - North Plainfield NJ, US
Ronald J. Doll - Convent Station NJ, US
Timothy J. Guzi - Sudbury MA, US
Danny J. Hicklin - Montclair NJ, US
Amin Nomeir - Milford NJ, US
Malcolm MacCoss - Brookline MA, US
International Classification:

A61K 31/4545
A61P 35/02
A61P 35/00
C07D 409/14
C07D 401/14
US Classification:

514316, 546187
Abstract:

The present invention provides a compound of Formula (1) as described herein or a pharmaceutically acceptable salt, solvate or ester thereof. The compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and methods of treating cancer using the same.